Stifel Reiterates Buy Rating on Rapid Micro Biosystems Inc (RPID) following Q4 report

March 16, 2026 8:58 AM

Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on Rapid Micro Biosystems Inc (NASDAQ: RPID)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found